Effects of oxotremorine and physostigmine on the turnover of dopamine in the corpus striatum and the limbic system.
D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects; D003342:Corpus Striatum / Q000032:analysis / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D006719:Homovanillic Acid / Q000032:analysis; D008032:Limbic System / Q000032:analysis / Q000378:metabolism*; D010095:Oxotremorine / Q000494:pharmacology*; D010830:Physostigmine / Q000494:pharmacology*; D011817:Rabbits; D012601:Scopolamine / Q000032:analysis / Q000494:pharmacology; D014282:Trihexyphenidyl / Q000494:pharmacology
D010095:Oxotremorine; D014282:Trihexyphenidyl; D010830:Physostigmine; D012601:Scopolamine; D004298:Dopamine; D006719:Homovanillic Acid